U.S. Energy Services Stock News

Earlier this year, ManpowerGroup reported quarterly revenue growth of 7.1% year on year, beating analyst expectations but missing EPS estimates, while highlighting progress in cost optimization, technology initiatives, and a disciplined transformation plan amid gradually stabilizing market trends. A separate initiative, the 2026 VivaTech Startup Challenge, underscores how ManpowerGroup is using AI to address talent shortages, with its latest survey showing employer demand for AI capabilities...

D-Wave Quantum (NYSE:QBTS) announced a new interview podcast series, "Quantum Matters". The series will highlight real world quantum applications across industries such as manufacturing, supply chain, aerospace, life sciences and AI. The podcast will feature conversations with sector leaders focused on practical use cases for quantum computing. D-Wave Quantum operates in the quantum computing space, with a focus on practical problem solving for businesses rather than purely academic...

Legence (LGN) has just posted another busy quarter, with Q3 FY 2025 revenue of US$708.0 million and a small loss, as Basic EPS landed at a US$0.02 loss and net income excluding extra items was a US$1.1 million loss. The company has seen revenue move from US$560.8 million in Q3 FY 2024 to US$708.0 million in Q3 FY 2025. Over the trailing 12 months, revenue reached about US$2.4 billion against a trailing 12 month net loss of US$19.8 million, putting the spotlight squarely on scaling margins...

Structure Therapeutics (NasdaqGM:GPCR) released highly positive Phase 2 topline data for its oral GLP-1 receptor agonist aleniglipron in obesity and overweight patients. The new results from the ACCESS clinical program show significant weight loss, a compelling safety and tolerability profile, and low discontinuation rates. The company plans to advance aleniglipron into Phase 3 trials based on these Phase 2 outcomes. Structure Therapeutics focuses on small molecule medicines, and...

Wondering whether Dutch Bros at around US$46.69 still makes sense for your portfolio, or if the price now bakes in too much optimism. The stock has had a mixed run, with a 6.6% decline over the last week, an 8.2% decline over the past month, a 24.9% decline year to date, yet a 47.6% return over three years. Recent coverage has focused on how Dutch Bros fits into the broader consumer services space and how sentiment toward growth oriented concepts has shifted over time. This context helps...

If you are wondering whether Dolby Laboratories at around US$58 per share offers value or a value trap, the starting point is understanding what the current price actually bakes in. The stock has recently pulled back, with returns of 3.8% over 7 days, 9.7% over 30 days and 8.7% year to date, adding to a 25.9% return over 1 year, 28.6% over 3 years and 38.8% over 5 years. Recent coverage around Dolby has focused on its position in audio and visual technologies and how it fits into broader...

Recent performance and what it might mean for TETRA Technologies (TTI) TETRA Technologies (TTI) has seen mixed share performance recently, with a 2.6% gain over the past day and 8.3% over the past week, compared with a decline of 22.6% over the past month and a 7.7% decline over the past three months. See our latest analysis for TETRA Technologies. Looking past the latest bounce, the 30 day share price return of negative 22.6% and year to date share price return of negative 11.95% sit against...

Zentalis Pharmaceuticals (ZNTL) has just posted its FY 2025 first half results with total revenue at US$0 million, basic EPS at a loss of US$1.05, and net income excluding extraordinary items at a loss of US$75.2 million. This puts the focus firmly on expense control and cash burn. Over the recent periods, the company has seen revenue move from US$40.6 million in the first half of 2024 to US$26.9 million in the second half of 2024, before dropping to zero in the latest half. Half year basic...

Wondering if Northwest Natural Holding at US$52.83 is priced attractively or already reflects most of its potential? This article walks through the numbers so you can judge the valuation for yourself. The stock has returned 2.7% over the last 7 days, 5.7% over 30 days, 13.0% year to date and 29.6% over 1 year, with 3-year and 5-year returns of 27.9% and 23.9% respectively. These returns naturally raise questions about what is now baked into the price. Recent coverage has focused on how gas...

Get Joy, a functional gut-healthy dog nutrition company, has already rolled out its Freeze Dried Raw Chicken and Beef Meals into more than 360 Sprouts Farmers Market stores nationwide, following its nationwide launch that began on April 6. This expansion broadens Sprouts’ better-for-you pet assortment, aligning its pet aisles with wellness trends that increasingly mirror how customers shop for their own nutrition. Next, we’ll explore how adding Get Joy’s gut-focused dog meals could influence...

JBS (NYSE:JBS) has been removed from the FTSE All-World Index. The change affects the company’s presence in a major global equity benchmark tracked by many passive funds. The decision may influence how both current and prospective shareholders assess JBS within global portfolios. JBS, trading at $17.03, has seen a return of 19.5% over the past week and 20.1% year to date, with a 3.8% return over the past 30 days. With a value score of 6, the stock sits in a segment of the market that some...

Wondering whether Arch Capital Group at around US$93 per share still offers value, or if most of the opportunity is already reflected in the price? This article focuses squarely on what the current valuation signals might be telling you. The stock has gained 1.2% over the last 7 days, while showing a 6.0% decline over 30 days and a slight 0.5% decline year to date, alongside a 1.7% decline over the last year and longer term returns of 44.8% over 3 years and 149.3% over 5 years. Recent...

Hilton Worldwide Holdings (HLT) has drawn fresh investor attention after reporting a quarter where revenue came in 3.3% above analyst expectations and EBITDA guidance for the next quarter also exceeded forecasts. Even with these earnings and guidance beats highlighting Hilton’s position within the consumer discretionary travel and vacation providers sector, the stock has moved lower since the release. This has raised questions about how the market is reading the update. See our latest...

If you are wondering whether Colgate-Palmolive at around US$84.29 is offering fair value or hiding a discount, this breakdown is designed to help you frame that question clearly. The share price has slipped around 1.0% over the last week and 12.8% over the last month, even though the year to date return is 8.5% and the 1 year return sits at 7.0% in decline, with 3 year and 5 year returns of 20.4% and 20.8% respectively. Recent attention on Colgate-Palmolive has centered on how the stock fits...

Recent performance snapshot Diversified Energy (DEC) has attracted fresh attention after a strong recent share price move, with the stock showing double digit gains over the past week, month and past 3 months. See our latest analysis for Diversified Energy. The recent surge in DEC's share price, with a 39.05% 1 month share price return and 22.70% year to date share price return, sits against a 44.68% 1 year total shareholder return but weaker 3 and 5 year total shareholder returns. This...

Earlier this week, Hartford Insurance Group reported a very strong quarter, with revenue rising 6.7% year on year and results significantly ahead of analyst expectations compared with peers. What stands out is that Hartford delivered the biggest analyst estimate beat among its sector group, underscoring how its recent performance contrasts with many competitors. Now we’ll explore how this strong revenue growth and earnings beat may influence Hartford’s existing investment narrative and key...

Globe Life stock in focus Globe Life (GL) is back on investors’ radar after recent share price moves, with the stock closing at US$135.11 and shorter term returns showing mixed performance over the past week and month. See our latest analysis for Globe Life. Recent share price returns have been soft, with a 6.27% 1 month share price decline and a 2.39% year to date share price decline. Longer term total shareholder returns of 4.97% over 1 year and 42.48% over 5 years point to steadier...

Brighthouse Financial (BHF) is back on investors’ radar after a recent share move. The stock is trading around $59.98, with performance over the past month and past 3 months in focus. See our latest analysis for Brighthouse Financial. Recent price action has softened, with a 90 day share price return of a 7.51% decline and a year to date share price return of a 7.11% decline. However, the 1 year total shareholder return of 4.22% and 3 year total shareholder return of 35.98% indicate that...

Estée Lauder Companies (NYSE:EL) has confirmed discussions about a potential business combination with Puig that could create one of the largest listed beauty firms globally. The company has also agreed to acquire the remaining interests in Indian luxury beauty brand Forest Essentials, moving toward full ownership. These developments arrive while Estée Lauder works through ongoing turnaround efforts and reassesses its global footprint. For shareholders watching NYSE:EL at a current share...

In March 2026, Itron, Inc. expanded its grid solutions footprint by supporting Ausgrid’s rollout of the IntelliFLEX LV DERMS platform in Australia and deepening its AI-powered distributed intelligence collaboration with NVIDIA for real-time grid-edge monitoring and anomaly detection. Together, these moves highlight Itron’s push toward higher-value software, analytics, and grid management capabilities that address increasingly complex reliability and safety needs for utilities. We’ll now...

Wondering if ASML Holding at around US$1,302 a share still offers value or if the easy gains are behind it? This article walks through the numbers so you can judge that for yourself. The stock has returned 11.9% year to date, 94.5% over the last year, and 112.7% over five years, but it has also seen a 1.1% pullback over the last week and a 14.7% decline over the last month. These recent moves come against a backdrop of ongoing attention on ASML Holding as a key supplier to the semiconductor...

Everest Group (NYSE:EG) has agreed to sell 100% of Everest Insurance Company of Canada to The Wawanesa Mutual Insurance Company. Following the announcement, AM Best placed Everest Canada’s financial strength and credit ratings under review with negative implications. The proposed transaction is subject to regulatory approvals and closing conditions, adding timing and execution uncertainty for investors and policyholders. Everest Group is a global reinsurance and insurance provider, and its...

Verra Mobility, NasdaqCM:VRRM, is reporting long term sales growth alongside pressure on free cash flow margins. Recent quarterly results show weaker profitability, prompting questions about investment needs and cost control. Investor sentiment has cooled, with the share price at $13.88 and a 37.8% decline year to date. For shareholders, the story around Verra Mobility is no longer just about sales momentum. The stock is down 37.8% year to date and 31.3% over the past year, with the current...

In March 2026, Smithfield Foods reported higher fourth-quarter and full-year 2025 results, issued 2026 guidance for low-single-digit sales growth, announced a quarterly dividend of US$0.3125 per share, and outlined an agreement to acquire the Nathan's Famous packaged meats brand while continuing to evaluate additional M&A opportunities. A key takeaway for investors is Smithfield Foods’ record 2025 operating profit of US$1.30 billion and margin expansion to 8.6%, highlighting improved...